Table 2.
Optimized activities (Aopt,i) determined in approaches 1–4 to calculation
| Activity calculation approach | TUG | NTG | TMG | GD | Unit |
|---|---|---|---|---|---|
| 1 | 540 (477) | 1229 (1342) | 627 (505) | 578 (882) | MBq |
| 2 | 69 (41) | 16 (10) | 15 (10) | 24 (26) | MBq g−1 |
| 3 | 1898 (1010) | 509 (189) | 513 (181) | 1424 (1328) | MBq % g−1 |
| 4 | 429 (229) | 120 (62) | 111 (72) | 117 (97) | MBq d g−1 |
Standard deviations are given in brackets. The ratio between optimized activities of TUG and the other disease entities far exceeds the ratio between target doses
GD Graves’ disease, NTG non-toxic nodular goiter, TMG toxic multinodular goiter, TUG toxic uninodular goiter